aTyr Pharma Inc (LIFE)
1.74
-0.02
(-1.14%)
USD |
NASDAQ |
May 31, 16:00
1.72
-0.02
(-1.15%)
After-Hours: 20:00
aTyr Pharma Price to Book Value: 1.422 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.422 |
| May 30, 2024 | 1.438 |
| May 29, 2024 | 1.373 |
| May 28, 2024 | 1.462 |
| May 24, 2024 | 1.471 |
| May 23, 2024 | 1.471 |
| May 22, 2024 | 1.520 |
| May 21, 2024 | 1.593 |
| May 20, 2024 | 1.691 |
| May 17, 2024 | 1.634 |
| May 16, 2024 | 1.577 |
| May 15, 2024 | 1.565 |
| May 14, 2024 | 1.487 |
| May 13, 2024 | 1.389 |
| May 10, 2024 | 1.381 |
| May 09, 2024 | 1.405 |
| May 08, 2024 | 1.381 |
| May 07, 2024 | 1.389 |
| May 06, 2024 | 1.356 |
| May 03, 2024 | 1.315 |
| May 02, 2024 | 1.307 |
| May 01, 2024 | 1.299 |
| April 30, 2024 | 1.283 |
| April 29, 2024 | 1.295 |
| April 26, 2024 | 1.270 |
| Date | Value |
|---|---|
| April 25, 2024 | 1.291 |
| April 24, 2024 | 1.295 |
| April 23, 2024 | 1.311 |
| April 22, 2024 | 1.327 |
| April 19, 2024 | 1.295 |
| April 18, 2024 | 1.311 |
| April 17, 2024 | 1.287 |
| April 16, 2024 | 1.303 |
| April 15, 2024 | 1.376 |
| April 12, 2024 | 1.408 |
| April 11, 2024 | 1.424 |
| April 10, 2024 | 1.432 |
| April 09, 2024 | 1.392 |
| April 08, 2024 | 1.481 |
| April 05, 2024 | 1.505 |
| April 04, 2024 | 1.513 |
| April 03, 2024 | 1.497 |
| April 02, 2024 | 1.489 |
| April 01, 2024 | 1.546 |
| March 31, 2024 | |
| March 28, 2024 | 1.461 |
| March 27, 2024 | 1.499 |
| March 26, 2024 | 1.435 |
| March 25, 2024 | 1.439 |
| March 22, 2024 | 1.457 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3604
Minimum
Aug 14 2019
8.437
Maximum
Sep 23 2021
1.211
Average
1.103
Median
Jan 09 2024
Price to Book Value Benchmarks
| Vaxart Inc | 2.613 |
| Allogene Therapeutics Inc | 1.127 |
| AIM ImmunoTech Inc | 4.487 |
| Protalix BioTherapeutics Inc | 2.781 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 1.74 |
| Earnings Yield | -51.72% |
| Market Cap | 120.08M |